Medical Devices News and Research

RSS

Cerner, Baxa sign strategic reseller agreement for DoseEdge Pharmacy Workflow Manager

Cerner Corporation and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge Pharmacy Workflow Manager. The agreement enables Cerner to market and resell the Baxa DoseEdge System as part of an integrated Cerner offering. Cerner clients now have access to a broader suite of solutions and certified integration for dose tracking from compounding to delivery.

6 Dec 2010

Marine life-inspired anti-microbial surfaces

Taking a leaf from animals like dolphins and pilot whales that are known to have anti-fouling skins, researchers from A*STAR's Industrial Consortium On Nanoimprint (ICON) are using nanotechnology to create synthetic, chemical-free, anti-bacterial surfaces. The surfaces can reduce infections caused by pathogens such as S. aureus and E. coli and can be used on common plastics, medical devices, lenses and even ship hulls. Conventional methods for preventing bacterial surface attachment may use potentially harmful metal ions, nanoparticles, chemicals or UV-radiation.

5 Dec 2010

University of Portland's school of engineering named after Bjork-Shiley heart valve inventor

University of Portland's school of engineering will now be known as the Donald P. Shiley School of Engineering in recognition of the late Donald Shiley, a 1951 graduate who was an engineer, inventor, entrepreneur, businessman, philanthropist and loving husband and father. Among his many groundbreaking inventions was the Bjork-Shiley heart valve, an innovative medical device that has been credited with saving more than a half million lives.

4 Dec 2010

HSS creates Center for Musculoskeletal Outcomes and Patient Oriented Research

Hospital for Special Surgery announced the creation of the Center for Musculoskeletal Outcomes and Patient Oriented Research to translate information collected from an extensive patient population into studies that will guide experts in preventing, diagnosing and treating musculoskeletal disorders.

4 Dec 2010

ETP, EF announce latest grant recipients of New Therapy Grants Program

The Epilepsy Therapy Project and the Epilepsy Foundation today announced the latest grant recipients of their New Therapy Grants Program, a unique joint venture of two non-profit epilepsy organizations, to advance promising epilepsy research in clinical development.

4 Dec 2010

Neurostimulation effective for management of chronic pain

St. Jude Medical, Inc., a global medical device company, today announced two-year results in a post-market clinical study evaluating neurostimulation (spinal cord stimulation) for the management of chronic low back pain. Presented at the 14th annual North American Neuromodulation Society (NANS) meeting in Las Vegas, the study found that 70 percent of neurostimulation patients reported overall pain relief of 50 percent or better at their final two-year visit.

4 Dec 2010

FDA Advisory Committee votes in favor of expanded use of LAP-BAND gastric band

Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the FDA extend the currently approved use of the LAP-BAND® System, Allergan's gastric band, on the basis of a favorable benefit-risk profile for weight reduction in obese adults who have failed more conservative weight reduction alternatives and have a Body Mass Index (BMI) of at least 35 or a BMI ≥30 and at least one comorbid condition.

4 Dec 2010

NetDimensions releases Enterprise Knowledge Platform version 6.3

NetDimensions, a global provider of performance, knowledge and Learning Management Systems (LMS), announced today the release of version 6.3 of the Enterprise Knowledge Platform (EKP), the company's award-winning learning management system.

3 Dec 2010

Sentara Heart Hospital commences procedures in AtriCure DEEP AF feasibility trial

Sentara Heart Hospital is breaking new ground in cardiac care and treatment. Surgeons and Cardiologists at Sentara Heart Hospital are first to begin enrolling and performing trial cases in the AtriCure DEEP AF feasibility trial. The first procedure in the country was performed in a new, state-of-the-art hybrid operating room at Sentara Heart Hospital by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.

3 Dec 2010

AtriCure initiates enrollment in DEEP AF feasibility trial

AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, announced initial patient enrollment in its DEEP AF feasibility trial. The first procedure was performed in a new, state-of-the-art hybrid room at Sentara Norfolk General Hospital in Norfolk, Virginia by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.

3 Dec 2010

HSS creates Center for Musculoskeletal Outcomes and Patient Oriented Research

Hospital for Special Surgery (HSS) announced the creation of the Center for Musculoskeletal Outcomes and Patient Oriented Research to translate information collected from an extensive patient population into studies that will guide experts in preventing, diagnosing and treating musculoskeletal disorders.

2 Dec 2010

PreCision Dermatology formed as a result of spin-out of Onset Therapeutics

PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.

2 Dec 2010

New radiation-free device to detect breast cancer

A new device may enable breast cancer screening and cancer detection in populations where mammography is not widely available or successful, including women in developing countries, and those under the age of 40.

2 Dec 2010

Mindray launches V Series patient monitoring system

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today introduced the Mindray V Series patient monitoring system, an all new scalable platform that focuses on the clarity and continuity of data at a single point of care. The V Series solution is the result of research focused on identifying the unique challenges of critical care and other high acuity environments.

From Mindray 2 Dec 2010

MiMedx awarded QTDP grant for CollaFix drug delivery device

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has been awarded a Qualifying Therapeutic Discovery Project grant (QTDP) from the U.S. Government. The grant, in the amount of $244,479, has been made to defer some of the Company's research expenditures related to the development of its novel and patented technology, CollaFix™, as a drug delivery device.

2 Dec 2010

Medical records and medical device interests gain attention from big names, congressional delegation

The Hill: "The new lobby shop of former Rep. Billy Tauzin (R-La.) and his son Tom has registered its first client. The San Francisco-based tech company Resilient Networks Systems has hired Tauzin Consultants to help lobby on the deployment of electronic medical records under the healthcare reform law among other issues, according to lobbying disclosure records.

30 Nov 2010

Spinal Modulation's Dorsal Root Ganglion Stimulation Pilot Clinical Trial results to be presented at 14th NANS

SPINAL MODULATION, Inc., a privately held medical device company focused on developing devices to treat chronic pain, today announced that the results of its prospective, multicenter Dorsal Root Ganglion (DRG) Stimulation Clinical Trial will be presented by David Caraway, MD, PhD, Timothy Deer, MD and Robert Levy, MD, PhD at the 14th Annual North American Neuromodulation Society (NANS) meeting.

30 Nov 2010

Mindray upgrades M7 ultrasound, high performance DC-7 platforms at RSNA annual meeting

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced two significant upgrades for its premium M7 ultrasound and high performance DC-7 platforms at the Radiology Society of North America (RSNA) being held in Chicago, November 28 – December 2, 2010. The hand carried M7 unit (HCU), which was recently introduced in North America, will be available with an extensive variety of new transducers

From Mindray 30 Nov 2010

Northern Hospital implements EMC and VMware solutions to virtualize and consolidate IT infrastructure

EMC Corporation, the world leader in information infrastructure solutions, today announced that Northern Hospital of Surry County, a community hospital in Mount Airy, N.C. with more than 850 healthcare professionals including physicians on staff, has implemented EMC and VMware solutions to virtualize and consolidate its IT infrastructure for increased efficiency, agility and data protection.

30 Nov 2010